- Home
- TCBP vs ALBT Comparison
TCBP vs ALBT Comparison
Compare TCBP & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- ALBT
- Stock Information
- Founded
- TCBP 2013
- ALBT 2014
- Country
- TCBP United Kingdom
- ALBT United States
- Employees
- TCBP N/A
- ALBT N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBP Health Care
- ALBT Health Care
- Exchange
- TCBP Nasdaq
- ALBT Nasdaq
- Market Cap
- TCBP 3.0M
- ALBT 3.1M
- IPO Year
- TCBP 2022
- ALBT N/A
- Fundamental
- Price
- TCBP $0.65
- ALBT $2.68
- Analyst Decision
- TCBP Strong Buy
- ALBT
- Analyst Count
- TCBP 1
- ALBT 0
- Target Price
- TCBP $3.00
- ALBT N/A
- AVG Volume (30 Days)
- TCBP 1.8M
- ALBT 2.6M
- Earning Date
- TCBP 02-09-2025
- ALBT 11-12-2024
- Dividend Yield
- TCBP N/A
- ALBT N/A
- EPS Growth
- TCBP N/A
- ALBT N/A
- EPS
- TCBP N/A
- ALBT N/A
- Revenue
- TCBP N/A
- ALBT N/A
- Revenue This Year
- TCBP N/A
- ALBT N/A
- Revenue Next Year
- TCBP N/A
- ALBT N/A
- P/E Ratio
- TCBP N/A
- ALBT N/A
- Revenue Growth
- TCBP N/A
- ALBT N/A
- 52 Week Low
- TCBP $0.44
- ALBT $2.11
- 52 Week High
- TCBP $41.50
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- TCBP 36.84
- ALBT 41.99
- Support Level
- TCBP $0.45
- ALBT $3.65
- Resistance Level
- TCBP $0.70
- ALBT $6.55
- Average True Range (ATR)
- TCBP 0.08
- ALBT 0.67
- MACD
- TCBP 0.10
- ALBT -0.02
- Stochastic Oscillator
- TCBP 55.58
- ALBT 7.86
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.